Respiratory tract infections (RTI) are a major cause of mortality and morbidity in children. Several studies have aim supplementation as a possible preventive measure against respiratory tract infections in children. Vitamin-D (sunshine vitamin) is a type of prohormone with various functions like extracellular calcium ion maintenance, immunomodulation in the body. The three major sources of Vitamin-D are Sun exposure, Diet and Supplements. The main objective of our study was to correlate the vitamin D deficiency in children with RTI’s. A prospective observational study was conducted for 6 months inpatient of the Pediatric department in tertiary care hospital. Demographic details, cause of admission, past medical and medication history, feeding history, sun exposure was taken by interviewing the guardian. Data of a total of 25 pediatric patients with various respiratory tract infection cases were collected, documented and their vitamin D levels were analyzed in our study. The vitamin D level of samples was analyzed by Electro chemiluminescence immunoassay. Statistical methods were applied and significant differences were observed among the vitamin D sufficient and deficient patients with RTI’s. It was observed that out of 25 cases, 16 cases had recurrent respiratory tract infections and 9 had non-recurrent respiratory tract infections which statistically shows P value < 0.05. This study significantly correlates vitamin D deficiency with respiratory tract infections in children. This study also suggests vitamin D as a supplement therapy as it plays an important role in the innate and the adaptive immunity.
Effects of supraphysiologic Glucocorticoid levels originating from exogenous administration of Glucocorticoids known as iatrogenic Cushing syndrome and endogenous overproduction by the adrenal gland (ACTH dependent) or by abnormal adrenocortical tissues (ACTH independent) known as ectopic Cushing syndrome. We report a case of a 50-year-old male patient with symptoms of abdominal distension, swelling of the face, fat deposition around the neck, buffalo hump, and loss of muscles in the upper limbs. The patient had a history of administration of Betamethasone 0.5mg for about 6 months and Methylprednisolone 16mg OD for 15 days. The patient was diagnosed with iatrogenic Cushing syndrome. The steroid dose was tapered gradually to bring back the adrenal function to a normal position. The co-morbid condition leads to the overall worsening of health condition. Therefore, strict control of the co-morbid condition must be a priority. Similar management strategies were adopted by slowly tapering the dose of steroids weekly along with the addition of Furosemide and Metformin to the treatment regimen to control the underlying co-morbid conditions. The case was well managed with appropriate guidelines followed by medication. Identification and diagnosis of this kind of clinical condition are not always clear and consistent. Hence, awareness of diverse forms of presentation of this disorder should be encouraged. Clinical pharmacists have to be aware of these rare syndromes and support the clinicians in whatever ability is required. Far outreach to all healthcare professionals in the form of such case studies can also be an additional tool to create awareness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.